Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration and Duke University. The purpose of this MOU is to establish a framework for collaboration between the Parties and for pursuing specific collaborative projects. This collaboration between the Parties shall be known as the Cardiac Safety Research Consortium.
The agreement became effective August 4, 2009.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Wendy R. Sanhai, Office of the Commissioner (HZ-1), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7867, FAX: 301-827-5891.End Further Info End Preamble Start Supplemental Information
In accordance with 21 CFR 20.108(c), Start Printed Page 46999which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.Start Signature
Dated: August 31, 2009.
Assitant Commissioner for Policy.
BILLING CODE 4160-01-S
[FR Doc. E9-22001 Filed 9-11-09; 8:45 am]
BILLING CODE 4160-01-C